Pennant Group (PNTG) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
Pennant Group insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 3 sold $690K of PNTG stock on the open market.
Get emailed when insiders cluster-buy stocks like PNTG
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
PNTG insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $532K | 5 |
| Q2 2026 | — | 0 | $158K | 4 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 Pennant Group, Inc. insiders reported open-market purchases totaling $0, while 3 insiders reported sales totaling $690K. 9 of 9 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 10SEC | Brent GuerisoliCEO | Sell Plan | 4,28599,544 held (−4%) | $38.52 | $165K | +3.1% | — |
| Aug 10SEC | Jason Paul SteikChief Clinical Officer | Sell Plan | 1,39415,106 held (−8%) | $38.52 | $54K | +3.1% | — |
| Aug 10SEC | Kirk Sterling CheneyEvp, Gc And Corp Secy | Sell Plan | 1,39318,401 held (−7%) | $38.52 | $54K | +3.1% | — |
| Jul 14SEC | Brent GuerisoliCEO | Sell Plan | 3,159103,829 held (−3%) | $41.57 | $131K | -4.4% | — |
| Jul 9SEC | Brent GuerisoliCEO | Sell Plan | 3,165100,740 held (−3%) | $40.51 | $128K | -1.9% | — |
| May 27SEC | Brent GuerisoliCEO | Sell Plan | 2,25497,656 held (−2%) | $35.08 | $79K | +13.3% | — |
| May 27SEC | Brent GuerisoliCEO | Sell Plan | 2,03295,647 held (−2%) | $35.08 | $71K | +13.3% | — |
| May 27SEC | Brent GuerisoliCEO | Sell Plan | 20095,447 held (−0%) | $35.10 | $7K | +13.2% | — |
| May 27SEC | Brent GuerisoliCEO | Sell Plan | 2297,679 held (−0%) | $34.86 | $767 | +14.0% | — |
Insiders at Pennant Group, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Brent GuerisoliCEO | — | $583K | Aug 10, 2026 | — |
| Jason Paul SteikChief Clinical Officer | — | $54K | Aug 10, 2026 | — |
| Kirk Sterling CheneyEvp, Gc And Corp Secy | — | $54K | Aug 10, 2026 | — |
PNTG stock: common questions
Are Pennant Group, Inc. insiders buying PNTG stock?
In the past 12 months, 0 insiders reported open-market purchases of PNTG worth $0.
Are Pennant Group, Inc. insiders selling PNTG stock?
3 insiders reported sales worth $690K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is PNTG's 52-week range?
Over the past year PNTG has traded between $23.64 and $42.48. It last closed at $39.73 on Oct 9, 2026.